Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Deterioration of the general state; rectal bleeding; Diarrhea; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB. Regulatory authority report number FR-AFSSAPS-LM20210585. A 78-year-old female patient received BNT162B2 (COMIRNATY), first dose on 28Jan2021 (Lot Number: EJ6795, unknown expiration) and second dose on 18Feb2021 (Lot Number: EM6950, unknown expiration), both via intramuscular in left arm as a single dose for COVID-19 immunisation. Medical history included bedridden and placed in palliative care. No history of COVID. The patient''s concomitant medications were not reported. It was reported that the patient experienced diarrhea on 29Jan2021 the day after the 1st dose, without real improvement until the 2nd dose when a rectal bleeding was associated on 19Feb2021. The patient had deterioration of the general state on 01Mar2021. The patient died following events diarrhea, bleeding rectal, and deterioration of the general state on 01Mar2021. It was unknown if an autopsy was performed. No follow-up attempts are possible; information about batch number was already obtained.; Reported Cause(s) of Death: Diarrhea; rectal bleeding; Deterioration of the general state
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166